Five-mer peptides prevent short-term spatial memory deficits in Aβ25-35-induced Alzheimer’s model mouse by suppressing Aβ25-35 aggregation and resolving its aggregate form
Abstract Background The development of drugs for Alzheimer’s disease (AD), which is related to the misfolding and aggregation of amyloid-β (Aβ), is high in demand due to the growing number of AD patients. In this study, we screened 22 kinds of 5-mer synthetic peptides derived from the Box A region o...
Main Authors: | Rina Nakamura, Motomi Konishi, Youichirou Higashi, Motoaki Saito, Toshifumi Akizawa |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-04-01
|
Series: | Alzheimer’s Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13195-023-01229-2 |
Similar Items
-
An 11-mer Synthetic Peptide Suppressing Aggregation of Aβ25-35 and Resolving Its Aggregated Form Improves Test Performance in an Aβ25-35-Induced Alzheimer’s Mouse Model
by: Rina Nakamura, et al.
Published: (2024-09-01) -
Structure–Activity Relationship of 5-mer Catalytides, GSGYR and RYGSG
by: Rina Nakamura, et al.
Published: (2022-11-01) -
Non-aggregated Aβ25-35 Upregulates Primary Astrocyte Proliferation In Vitro
by: Elise C. Ohki, et al.
Published: (2017-09-01) -
Protective Effects of Fucoidan on Aβ25–35 and d-Gal-Induced Neurotoxicity in PC12 Cells and d-Gal-Induced Cognitive Dysfunction in Mice
by: Hengyun Wei, et al.
Published: (2017-03-01) -
Inhibitory effects of Tabernaemontana divaricata root extract on oxidative stress and neuronal loss induced by amyloid β25–35 peptide in mice
by: Onrawee Khongsombat, et al.
Published: (2018-01-01)